Novartis Ceo: Setting Up Sandoz For Next Wave Of Growth

Vas Narasimhan, chief executive officer at Novartis AG, discusses the future of the generics business Sandoz, the outside interest in the unit and the roll out for its new Multiple Sclerosis treatment. He speaks on "Bloomberg Markets: Europe."

#bloomberg